Jain PharmaBiotech, May 2012, Pages: 1037
in management of breast cancer
Tests for prognosis of breast cancer
Prediction of recurrence in breast cancer for personalizing therapy
Cervical cancerColorectalcancer
ColoVantage CRC test
Detection
Espicom Business Intelligence Ltd, Sep 2007, Pages: 184
and colorectalcancer.
But there are many challenges ahead
It is still not clear how best to use cancer vaccines with respect to disease stage and in combination with other therapies. How should clinical trials
Espicom Business Intelligence Ltd, Sep 2007
, non-small cell lung and colorectalcancer.
But there are many challenges ahead
It is still not clear how best to use cancer vaccines with respect to disease stage and in combination with other
Espicom Business Intelligence Ltd, Aug 2011, Pages: 382
and scoring of 72 major breast cancer treatments
Comprehensive market assessment of therapeutic approaches, company share, portfolios and prospects
Breast Cancer Therapy Sales Forecast 2010 - 2017
'What
Global Industry Analysts, Inc., Oct 2010, Pages: 360
47
Major Developments in the Treatment Area of Breast Cancer 47
Colorectalcancer 48
Prostate Cancer
Espicom Business Intelligence Ltd, May 2007, Pages: 124
Cancer Drug Discoveries: what the future holds: ColorectalCancer Chapter Colorectalcancer (CRC) is the third most common cancer in the US in both sexes and accounts for around 10% of all cancer
GlobalData, June 2011, Pages: 82
either brivanib alaninate versus placebo in patients with chemotherapy-refractory KRAS wild-type (WT) advanced colorectalcancer (aCRC): The NCIC CTG/AGITG CO.20 trial.
2.6.6 Randomized Phase III Study
Life Science Intelligence, Inc., Dec 2009, Pages: 1763
for the risk assessment of cardiovascular disease and the detection of early-stage lung/breast/colorectalcancer
- Diagnostic and therapeutic catheter-based devices for prevention/treatment of heart attacks
Business Insights, Aug 2006, Pages: 156
treatment
Metabolomics for biomarker discovery
Case study: Phenomenome Discoveries colorectalcancer biomarker
Case Study: biomarkers of asthma from the University of Alberta, Canada
The challenge of human
TriMark Publications, July 2011, Pages: 335
Cancer
3.2.5.3.1 PCA3
3.2.5.3.2 Companies Active in Molecular Diagnostics and Prostate Cancer Analysis
3.2.5.4 Chronic Myelogenous Leukemia
3.2.5.5 Malignant Gliomas
3.2.5.6 ColorectalCancer
3
Life Science Intelligence, Inc., July 2007
-of-care platform technology (CRP & Cyst C) for assessing risk of cardiovascular disease and renal dysfunction
Company 64 - Nanotechnology-based cancer therapy with contactless activation of tumor-specific
Marketstrat Inc, Nov 2009, Pages: 526
treated in the US alone. Colorectalcancer is the second most common cause of cancer deaths in the US, 60 percent of which are preventable with early detection. Prevalence of IBD or inflammatory bowel
Frost & Sullivan, March 2004
. Incidence of ColorectalCancer
4. Ratio of OTC Pharmaceuticals to Total Pharmaceuticals Market
5. Per Capita Healthcare Expenditure
List Of Figures
Chapter 2
Total Prebiotics
